Related Experiment Video
Updated: Jan 17, 2026

Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration
Published on: September 12, 2014
Polymers of intrinsic microporosity (PIMs) with immobilized carbonic anhydrase (CA) for extracorporeal membrane
Xingci Liu1, Lunhao Zhi1, Chong Cheng1
1College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu, 610065, People's Republic of China. sunshudong@scu.edu.cn.
Abstract:
Extracorporeal membrane oxygenation (ECMO) is widely used to save patients with severe respiratory failure. Although the mainstream ECMO membrane material poly(4-methyl-1-pentene) (PMP) provides excellent gas permeability, its hydrophobicity leads to thrombosis during clinical application. Recently, polymers of intrinsic microporosity (PIMs), characterized by high fractional free volume, have emerged as promising alternatives due to their superior permeability and convenient chemical modification. In our previous research, two modified PIM-1 (a typical PIM) membranes, amidoxime-functionalized (AO-PIM-1) and carboxyl/amide-functionalized (C-PIM-1), demonstrated enhanced hemocompatibility and gas-exchange performance. Nevertheless, effective CO2 removal remains challenging since CO2 predominantly exists as bicarbonate (HCO3-) ions in blood. Physiologically, carbonic anhydrase (CA) in alveoli could catalyze the conversion of HCO3- to CO2. Inspired by this natural mechanism, in this study, CA was immobilized onto PIM-1 membranes via 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxy succinimide (NHS) coupling. Different grafting conditions including grafting methods and types of PIM-1 substrates were explored. AO-PIM-1 showed optimal enzyme immobilization efficiency (78.35%), of which the immobilized CA retained 89.03% of initial activity after 14 days (versus 39.7% for free CA). ECMO simulation tests confirmed significantly enhanced CO2 removal due to CA catalytic activity. This study provides a promising approach to developing advanced ECMO membranes, addressing current bottlenecks in membrane oxygenator technology, as well as offers a reference for grafting enzymes onto PIMs.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

